Highlighting Resiliency During Multiple Myeloma Awareness Month 2021 Multiple myeloma is not easily diagnosed, and its early symptoms may be confused for another condition. Each March, Multiple Myeloma Awareness Month puts multiple myeloma (MM) in the spotlight. A rare cancer, MM is not easily diagnosed early on, but it is the second most common blood […]

It will be an emotional night as St. Francis plays first game without coach Jim Bonds on Saturday It will be an emotional night for the St. Francis football team when it travels to play Mira Costa on Saturday in their coronavirus-shortened season spring opener at 7 p.m., because for the first time in two […]

Oncology Care Pharmacy Has Promising Trends on the Horizon Expanded Pharmacist Roles in Oncology Pharmacists should ensure that patients have at least a 30-day supply of their oncology medications and continue to emphasize the importance of wearing a mask, frequent hand washing, social distancing, and avoiding travel during the pandemic.1 In an interview with Pharmacy […]

The Market at 25th to raise awareness on Multiple Myeloma [unable to retrieve full-text content] Multiple Myeloma is a cancer of the plasma cells beginning in the bone marrow. The partnership will be raising awareness for the rest of the month of …Published at Wed, 10 Mar 2021 18:33:45 +0000

Cyclin-dependent Kinase Inhibitor Market 2021 | Extensive Market Growth | Opportunities | Impact … A complete report on Cyclin-dependent Kinase Inhibitor Market was published by The Data Bridge Market Research to understand the comprehensive setup of Cyclin-dependent Kinase Inhibitor Market industries. Cyclin-dependent Kinase Inhibitor market research report provides professional and broad market report primary and […]

Is it Time to Dump XTL Biopharmaceuticals Ltd (XTLB) Stock After it Has Gained 3.42% in a Week? Overall market sentiment has been down on X T L Biopharmaceuticals Ltd (XTLB) stock lately. XTLB receives a Bearish rating from InvestorsObserver’s Stock Sentiment Indicator. X T L Biopharmaceuticals Ltd has a Bearish sentiment reading. Find out […]

Multiple Myeloma CAR T-Cell Therapy Achieves Response in 73% Patients Multiple Myeloma CAR T-Cell Therapy Achieves Response in 73% of Patients clinicalomicsprowebdirectory Scroll Up MORE CONTENT We use cookies to give you a better experience on clinicalomics.com. By continuing to use our site, you are agreeing to the use of cookies as set in our […]

Smoldering multiple myeloma: Early detection and intervention approaches by Dr. Mark Bustoros Mark Bustoros, MD provides an update on the research of early detection of multiple myeloma and intervention approaches that have the potential to greatly improve outcomes for multiple myeloma patients.

PLEIADES: Daratumumab combinations for multiple myeloma Dr Ajai Chari talks to ecancer at the International Myeloma Workshop 2019 about the PLEIADES studies. The studies look at daratumumab in combination with a variety of standard multiple myeloma treatment regimens. Dr Chari outlines some of the data from this trial, as well as any toxicities. Sign up […]

Expert Says CAR T-Cell Therapies Could Make Cancer a Chronic Disease In a recent interview with Pharmacy Times, Lee Greenberger, PhD, chief medical officer of the Leukemia and Lymphoma Society, said the development of chimeric antigen receptor (CAR) T-cell therapies is a major step for the treatment of some cancers. In a recent interview with […]